Anti-ischemic intervention as prognosis improvement in patients with coronary artery disease, with special focus on verapamil

American Journal of Cardiology

Volumn 77, Issue 16, 1996, Pages 32D-36D

  Jespersen, Christian M ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

VERAPAMIL;

ANGINA PECTORIS; CORONARY ARTERY DISEASE; DRUG EFFECT; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; THROMBOCYTE AGGREGATION INHIBITION;

EID: 0030015710     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00306-2     Document Type: Article

References (64)

1. Opie LH. Clinical use of calcium channel antagonist drugs. London: Kluwer Academic Publishers, 1990.
2. The Danish Study Group on Verapamil in Myocardial Infarction. Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II - DAVIT II). Am J Cardiol 1990;66:779-785.
3. Jespersen CM, The Danish Study Group on Verapamil in Myocardial Infarction. Role of ischemia in post infarction heart failure: hypothetical considerations based on use of verapamil in the DAVIT II study. Cardiovasc Drugs Ther 1994;8:823-828.
4. Jespersen CM, Hansen JF, Mortensen LS, The Danish Study Group on Verapamil in Myocardial Infarction. The prognostic significance of postinfarction angina pectoris and the effect of verapamil on the incidence of angina pectoris and prognosis. Eur Heart J 1994;15:270-276.
5. The Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981;304:801-807.
6. Jespersen CM. Anti-ischaemic intervention with verapamil in patients recovering from acute myocardial infarction. Eur Heart J 1995;16(suppl H):13-17.
7. Raymenants E, Yang B, Nicolini F, Behrens P, Lawson D, Mehta JL. Verapamil and aspirin modulate platelet-mediated vasomotion in arterial segments with intact or disrupted endothelium. J Am Coll Cardiol 1993;22:684-689.
8. Lacoste L, Lam JYT, Hung J, Waters D. Oral verapamil inhibits platelet thrombus formation in humans. Circulation 1994;89:630-634.
9. Wallén NH, Held C, Rehnqvist N, Hjemdahl P. Platelet aggregability in vivo is attenuated by verapamil but not by metoprolol in patients with stable angina pectoris. Am J Cardiol 1995;75:1-6.
10. Willich SN, Pohjola-Sintonen S, Bhatia SJS, Shook TL, Tofler GH, Müller JE, Curtis DG, Williams GH, Stone PH. Suppression of silent ischemia by metoprolol without alteration of morning increase of platelet aggregability in patients with stable coronary artery disease. Circulation 1989;79:557-565.
11. Rehnqvist N, Hjemdahl P, Billing E, Björkander I, Eriksson SV, Forslund L, Held P, Näsman P, Wallen NH. Prevention of cardiac events in patients with angina pectoris. Results of the APSIS study. Eur Heart J 1995;16(suppl H):18.
12. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146-1149.
13. Greenberg H, McMaster P, Dwyer EM. The Multicenter Postinfarction Research Group. Left ventricular dysfunction after acute myocardial infarction: results of a prospective multicenter study. J Am Coll Cardiol 1984;4:867-874.
14. Pisterer M, Zuber M, Wenzel R, Burkart F. Prolonged myocardial stunning after thrombolysis: can left ventricular function be assessed definitely at hospital discharge? Eur Heart J 1991;12:214-217.
15. Giannuzzi P, Marcassa C, Temporelli PL, Galli M, Corra U, Imparato A, Silva P, Gattone M, Campini R, Giordano A, Tavazzi L. Residual exertional ischemia: an unfavourable left ventricular remodelling in patients with systolic dysfunction after anterior myocardial infarction. J Am Coll Cardiol 1995;25:1539-1546.
16. Packer M. Calcium channel blockers in chronic heart failure. The risk of "physiologically rational" therapy. Circulation 1990;82:2254-2257.
17. Chadda K, Goldstein S, Byington R, Curb JD. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Circulation 1986;73:503-510.
18. Jespersen CM, The Danish Study Group on Verapamil in Myocardial Infarction. The effect of verapamil on major events in patients with impaired cardiac function recovering from acute myocardial infarction. Eur Heart J 1993;14:540-545.
19. Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988;319:385-392.
20. Goldstein RE, Boccuzzi SJ, Cruess D, Nattel S, the Adverse Experience Committee, the Multicenter Diltiazem Postinfarction Research Group. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. Circulation 1991;83:52-60.
21. Radice M, Giudici V, Albertini A, Mannarini A. Paradoxical effect of longterm treatment of nifedipine on total ischemic load in patients with stable angina pectoris. Clin Cardiol 1992;15:98-102.
22. Thadani U, Zellner SR, Glasser S, Bittar N, Montoro R, Miller AB, Chaitman B, Shulman P, Stahl A, DiBianco R, Bray J, Means WE, Morledge J. Double-blind, dose response, placebo-controlled multicenter study of nisoldipine. Circulation 1991;84:2398-2408.
23. Waters D. Proischemic complications of dihydropyridine calcium channel blockers. Circulation 1991;84:2598-2600.
24. Goldbourt U, Behar S, Reicher-Reiss H, Zion M, Mandelzweig L, Kaplinsky E for the SPRINT Study Group. Early administration of nifedipine in suspected acute myocardial infarction. The secondary prevention reinfarction Israel Nifedipine Trial 2 study. Arch Intern Med 1993;153:345-353.
25. Elkyam U, Amin J, Mehra A, Vasquez J, Weber L, Rahimtoola SH. A prospective, randomized, double-blind, crossover study to compare efficacy and safety of chronic nifedipine therapy with that of dinitrate and their combination in the treatment of chronic congestive heart failure. Circulation 1990;82:1954-1951.
26. Anderson B, Lomsky M, Waagstein F. The link between haemodynamic adrenergic beta-blockade and long-term effects in patients with heart failure. A study on diastolic function heart rate and myocardial metabolism following intravenous metoprolol. Eur Heart J 1993;14:1375-1385.
27. Przyklenk K, Kloner RA. Effect of verapamil on postischemic "stunned" myocardium: importance of the timing of treatment. J Am Coll Cardiol 1988;11:614-623.
28. Fischer Hansen J. Verapamil prevents sudden death in patients with increased heart size after an acute myocardial infarction. Cardiovasc Drugs Ther 1993;7:381-382.
29. Aronow WS, Mercando AD, Epstein S, Kronzon I. Decrease in mortality by propranolol on patients with heart disease and complex ventricular arrhythmias is more an anti-ischaemic than an antiarrhythmic effect. Am J Cardiol 1994;74:613-615.
30. Betocchi S, Piscione F, Perrone-Filardi P, Pace L, Capelli-Bigazzi M, Alfano B, Ciarmiello A, Salvatore M, Condorelli M, Chiariello M. Effects of intravenous verapamil on left ventricular relaxation and filling in stable angina pectoris. Am J Cardiol 1990;66:818-825.
31. Behar S, Zahavi Z, Goldbourt U, Reicher-Reiss H, The Sprint Study Group. Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction. Eur Heart J 1992;13:45-50.
32. Jespersen CM, Vaage-Nilsen M, Hansen JF, The Danish Study Group on Verapamil in Myocardial Infarction. The significance of myocardial ischaemia and verapamil treatment on the prevalence of supraventricular tachyarrhythmias in patients recovering from acute myocardial infarction. Eur Heart J 1992;13:1427-1430.
33. Bigger JT, Coromilas J, Rolnitzky LM, Fleiss JL, Kleiger RE, and the Multicenter Diltiazem Postinfarction Trial Investigators. Effect of diltiazem on cardiac rhythm after acute myocardial infarction. Am J Cardiol 1990;65:539-546.
34. The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983;309:331-336.
35. Bigger T, Fleiss JL, Rolnitzky LM, and the Multicenter Post-Infarction Research Group. Prevalence, characteristics and significance of ventricular tachycardia detected by 24-hour continuous electrocardiographic recordings in the late hospital phase of acute myocardial infarction. Am J Cardiol 1986;58:1151-1160.
36. Hinkle LE, Thaler HT. Clinical classification of cardiac death. Circulation 1982;65:457-464.
37. Kostis JB, Byiington R, Friedman LM, Goldstein S, Furberg C, for the BHAT Study Group. Prognostic significance of ventricular ectopic activity in survivors of acute myocardial infarction. J Am Coll Cardiol 1987;10:231-242.
38. Myerburg RJ, Bassett AL, Kimura S, Furukawa T, Kozlovski PL. Electrophysiological properties of the heart with healed myocardial infarction. In: Rosen MR, Janse MJ, Wit AL, eds. Cardiac Electrophysiology: A Textbook. New York: Futura Publishing, 1990:773-790.
39. Hohnloser SH, Kasper W, Zehender M, Geibel A, Meinetz T, Just H. Silent ischemia as a predisposing factor for ventricular/fibrillation. Am J Cardiol 1988;61:461-463.
40. Gülker H, Heuer H, Behrenbeck T, Godejohann U, Bender F. Prophylaxis of exercise-induced ventricular arrhythmias by verapamil. Eur Heart J 1987;8(suppl G):85-90.
41. Plotnick GD, Fisher ML, Backer LC. Ventricular arrhythmias in patients with rest angina: correlation with ST segment changes and extent of coronary atherosclerosis. Am Heart J 1983;105:32-36.
42. Carboni GP, Lahiri A, Casman PMM, Raftery EB. Mechanisms of arrhythmias accompanying ST-segment depression on ambulatory monitoring in stable angina pectoris. Am J Cardiol 1987;60:1246-1253.
43. Turitto G, Zanchi E, Maddaluna A, Pelligrini A, Risa AL, Prati PL. Prevalence, time course and malignancy of ventricular arrhythmia during spontaneous ischemic ST-segment depression. Am J Cardiol 1989;64:900-904.
44. Hausmann D, Nikutta P, Trappe H-J, Daniel WG, Wenzlaff P, Lichtlen PR. Incidence of ventricular arrhythmias during transient myocardial ischaemia in patients with stable coronary artery disease. J Am Coll Cardiol 1990;16:49-54.
45. Stern S, Banai S, Keren A, Tzivoni D. Ventricular ectopic activity during myocardial ischemic episodes in ambulatory patients. Am J Cardiol 1990;65:412-416.
46. Jespersen CM, Vaage-Nilsen, The Danish Study Group on Verapamil in Myocardial Infarction. Ventricular arrhy-thmias in patients recovering from myocardial infarction. Does residual myocardial ischemia and anti-ischemic medical intervention influence the one-month prevalence? Clin Cardiol 1993;16:109-114.
47. Packer M. Lack of relation between ventricular arrhythmias and sudden death in patients with chronic heart failure. Circulation 1992;85(suppl I):I-50-I-56.
48. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-412.
49. Hine LK, Laird NM, Chalmers TC. Meta-analysis of empirical-long-term antiarrhythmic therapy after acute myocardial infarction. JAMA 1989;262:3037-3040.
50. Anderson JL, Platia EV, Hallstrom A, Henthorn RW, Buckingham A, Carlson MD, Carson PE, Cardiac Arrhythmia Suppression Trial (CAST) investigators. Interaction of baseline characteristics with the hazard of encainide, flecainide, and moricizine therapy in patients with myocardial infarction. A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST). Circulation 1994;90:2843-2852.
51. Tsuneaki S, Ogawa S. Ischemia enhances use-dependent sodium channel blockade by pilsicainide, a class IC antiarrhythmic agent. J Am Coll Cardiol 1994;23:1378-1381.
52. Niclaes JM, McKenna WJ, Stewart RA, Mickelson JK, Das SK, Schork MA, Krikler SJ, Quain LA, Morady F, Pitt B. Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy. Am Heart J 1991;122:1016-1021.
53. Pratt CM, Eaton T, Francis M, Woolbert S, Mahmarian J, Roberts R, Young JB. The inverse relationship between baseline left ventricular ejection fractio and outcome of antiarrhythmic therapy: a dangerous imbalance of the risk-benefit ratio. Am Heart J 1989;118:433-440.
54. Kennedy HL, Brooks MM, Barker AH, Bergstrand R, Huther ML, Beanlands DS, Bigger JT, Goldstein S, for the CAST Investigators. Beta-blocker therapy in the Cardiac Arrhythmia Suppression Trail. Am J Cardiol 1994;74:674-680.
55. Lichstein E, Morganroth J, Harrist R, Hubble E, for the BHAT Study Group. Effect of propranolol on ventricular arrhythmias. The Beta-Blocker Heart Attack Trial Experience. Circulation 1983;67(suppl I):5I-10I.
56. The Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981;304:801-807.
57. Lippe von der G, Lund-Johansen P, Kjekshus J. Effect of timolol on late ventricular arrhythmias after acute myocardial infarction. Acta Med Scand 1981;651(suppl):231-242:
58. Aronow WS, Ahn C, Mercando AD, Epstein S, Kronzon I. Decrease on mortality by propranolol in patients with heart disease and complex ventricular arrhythmias is more an anti-ischemic than an antiarrhythmic effect. Am J Cardiol 1994;74:613-615.
59. Vaage-Nilsen M, Rasmussen V, Hansen JF, Hagerup L, Sørensen MB, Pedersen-Bjergaard O, Mellemgaard K, Holländer NH, Nielsen I, Sigurd B, DAVITT II Study Group. Effect of verapamil on arrhythmias and heart rate during 16 months after acute myocardial infarction. Cardiovasc Drugs Ther 1994;8:147-151.
60. Stramba-Badiale M, Lazzarotti M, Facchini M, Schwartz. Malignant arrhythmias and acute ischemia: interaction between flecainide and the autonomic nervous system. Am Heart J 1994;128:973-982.
61. Temesy-Armos PN, Legenza M, Southworth SR, Hoffman BF. Effects of verapamil and lidocaine in a canine model of sudden coronary death. J Am Coll Cardiol 1985;6:674-681.
62. Luketich J, Friehling TD, O'Connor KM, Kowey PR. The effect of betaadrenergic blockade on vulnerability to ventricular fibrillation and inducibility of ventricular arrhythmia in short and long-term feline infarction model. Am Heart J. 1989;118:265-271.
63. Nayler WG, Sturrock WJ. An inhibitory effect of verapamil and diltiazem on the release of noradrenaline from ischaemic and reperfused hearts. J Mol Cell Cardiol 1983;16:331-344.
64. Schomic A, Rehmert G, Kurz T, Richard G. Calcium antagonism and norepinephrine release in myocardial ischemia. J Cardiovasc Pharmacol 1992;20(suppl 7):S16-S20.